Lymphocyte blastogenesis induced by autochthonous human solid tumor cells

relationship to stage of disease and serum factors

G. M. Mavligit, Evan M Hersh, C. M. McBride

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Tumor induced blastogenesis was detected in vitro in autologous lymphocytes from 19 of 29 patients with solid tumors. The blastogenic response was dose related, and maximum response required a tumor cell lymphocyte ratio of 1:1. The intensity of response correlated inversely with the extent of disease. Tumor cells from patients with widespread disease seem to have a lower stimulatory capacity regardless of their site of origin (primary or metastatic lesion). The effect of serum from cancer patients on the blastogenic response was mostly nonspecific, and could be both inhibitory or facilitory. It did not correlate with the extent of disease.

Original languageEnglish (US)
Pages (from-to)1712-1721
Number of pages10
JournalCancer
Volume34
Issue number5
StatePublished - 1974
Externally publishedYes

Fingerprint

Lymphocyte Activation
Lymphocytes
Serum
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lymphocyte blastogenesis induced by autochthonous human solid tumor cells : relationship to stage of disease and serum factors. / Mavligit, G. M.; Hersh, Evan M; McBride, C. M.

In: Cancer, Vol. 34, No. 5, 1974, p. 1712-1721.

Research output: Contribution to journalArticle

@article{9ab205ac27e44c2cb9baee3159ecac08,
title = "Lymphocyte blastogenesis induced by autochthonous human solid tumor cells: relationship to stage of disease and serum factors",
abstract = "Tumor induced blastogenesis was detected in vitro in autologous lymphocytes from 19 of 29 patients with solid tumors. The blastogenic response was dose related, and maximum response required a tumor cell lymphocyte ratio of 1:1. The intensity of response correlated inversely with the extent of disease. Tumor cells from patients with widespread disease seem to have a lower stimulatory capacity regardless of their site of origin (primary or metastatic lesion). The effect of serum from cancer patients on the blastogenic response was mostly nonspecific, and could be both inhibitory or facilitory. It did not correlate with the extent of disease.",
author = "Mavligit, {G. M.} and Hersh, {Evan M} and McBride, {C. M.}",
year = "1974",
language = "English (US)",
volume = "34",
pages = "1712--1721",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Lymphocyte blastogenesis induced by autochthonous human solid tumor cells

T2 - relationship to stage of disease and serum factors

AU - Mavligit, G. M.

AU - Hersh, Evan M

AU - McBride, C. M.

PY - 1974

Y1 - 1974

N2 - Tumor induced blastogenesis was detected in vitro in autologous lymphocytes from 19 of 29 patients with solid tumors. The blastogenic response was dose related, and maximum response required a tumor cell lymphocyte ratio of 1:1. The intensity of response correlated inversely with the extent of disease. Tumor cells from patients with widespread disease seem to have a lower stimulatory capacity regardless of their site of origin (primary or metastatic lesion). The effect of serum from cancer patients on the blastogenic response was mostly nonspecific, and could be both inhibitory or facilitory. It did not correlate with the extent of disease.

AB - Tumor induced blastogenesis was detected in vitro in autologous lymphocytes from 19 of 29 patients with solid tumors. The blastogenic response was dose related, and maximum response required a tumor cell lymphocyte ratio of 1:1. The intensity of response correlated inversely with the extent of disease. Tumor cells from patients with widespread disease seem to have a lower stimulatory capacity regardless of their site of origin (primary or metastatic lesion). The effect of serum from cancer patients on the blastogenic response was mostly nonspecific, and could be both inhibitory or facilitory. It did not correlate with the extent of disease.

UR - http://www.scopus.com/inward/record.url?scp=0016282981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016282981&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 1712

EP - 1721

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -